Thomas Tursz

Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen.

B. Caillou, T. Tursz, C. Lingwood, 1993, Cancer research.

Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials.

R. Arriagada, S. Michiels, F. André, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.

J. Yodoi, T. Tursz, H. Wakasugi, 1990, Proceedings of the National Academy of Sciences of the United States of America.

ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-I and EBV.

J. Yodoi, T. Tursz, Thomas Tursz, 1991, Advances in cancer research.

Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: Prevalence of alterations in inflammatory breast cancers

L. Zelek, M. Mathieu, M. Kaghad, 2000, Oncogene.

Kinetic analysis of choriocarcinoma cell intoxication induced by ricin and ricin A chain immunotoxin.

M. Lipinski, T. Tursz, J. Le Pecq, 1988, Cancer research.

Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells.

T. Tursz, L. Pritchard, D. Coulaud, 1997, Blood.

High concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells.

T. Tursz, K. Fizazi, P. Busson, 1997, Virology.